Pemetrexed-Platinum With or Without Bevacizumab for Chinese Chemo-Naive Advanced Lung Adenocarcinoma Patients: A Real-World Study

Despite recent advances in the treatment of advanced non–small-cell lung cancer (NSCLC), bevacizumab plus platinum–based doublet chemotherapy remains a commonly used first-line regimen. This study was conducted to compare the efficacy and safety of pemetrexed–platinum with or without bevacizumab in...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin, Huang, Jie, Qiu, Yao, Zhang, Qianyun, Yang, Shaoyu, Wu, Kan, Wang, Jiaoli, Wang, Limin, Ye, Jian, Ma, Shenglin, Xia, Bing, Chen, Xueqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138310/
https://www.ncbi.nlm.nih.gov/pubmed/34025415
http://dx.doi.org/10.3389/fphar.2021.649222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138310/
https://www.ncbi.nlm.nih.gov/pubmed/34025415
http://dx.doi.org/10.3389/fphar.2021.649222

Ejemplares similares